financetom
Business
financetom
/
Business
/
France's Lactalis says no deal signed on possible Fonterra units purchase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
France's Lactalis says no deal signed on possible Fonterra units purchase
May 26, 2025 12:02 AM

PARIS (Reuters) - Lactalis, the world's largest dairy group, is interested in international investments but has not signed an agreement to buy parts of New Zealand-based dairy giant Fonterra, it said on Friday following reports it was considering an offer.

The French, privately owned company was among those considering bidding for units Fonterra is seeking to divest in a $2.37 billion deal, Reuters reported on Thursday.

Australia's competition watchdog said on Friday it had begun an informal review of an offer from Lactalis to buy New Zealand-based Fonterra's businesses, even though Lactalis has yet to make a formal announcement.

Asked about the bid, Lactalis said no deal had been signed.

"We would envisage many interested parties would participate in the sale process. Several pre-emptive steps are standard ahead of any agreement being considered, and Lactalis has not signed an agreement," it said.

"Lactalis has successfully enhanced its product offering internationally through acquisitions," it said further, adding global development was core to its plans for growth and it was considering international investments, including in Australia.

Two sources told Reuters that a deal could value the businesses Fonterra is seeking to sell at around NZ$4 billion ($2.37 billion).

New Zealand-based Fonterra in November made public a plan to either sell the units or list them through an initial public offering so it could focus on its core activity of processing milk at home.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved